It is estimated that approximately 1% of babies born per year result from in vitro fertilization and embryo transfer, and other assisted reproductive technologies. In humans, the exact mechanisms that lead to embryonic attachment to the endometrial epithelium and invasion into the endometrial stroma have not been fully characterized. The aim of the study is to estimate serum total adenosine deaminase and isoenzymes ADAl, ADA2, as well as MMP-2, MMP-3, MMP-13 and MIP-la as parameters for pregnancy following IVF-ET. The study group comprised seventeen women who conceived (Group A) and nineteen women aged 21-42 years who did not conceive (Group B) after IVF-ET. Blood samples were collected between 09.00 and 10.00 a.m. during IVF-ET treatment at two different periods. The first blood sample was collected before ET and the second sample 14 days after ET. All serum samples were assayed for the MMP-2, MMP-3 MMP-13 and MIP-la concentrations with ELISA assay. Serum tADA activity was measured by a spectrophotometer using adenosine as the substrate (Method by Giusti). According to our results it was demonstrated that women who successfully conceived after IVF-ET showed significantly lower serum concentrations of ADA1, MMP-2, MMP-3 and higher serum concentration of MMP-13 at 14 days following ET. In conclusion, ADAI may playa protective role at the hemochorial interface. Thus, our results suggest that ADAI may have a modulatory role in the implantation and duration of the pregnancy. In women with successful or unsuccessful pregnancy compared with normal women the levels of ADA and MMPs may be affected by the exogenous hormone therapy according to the protocol of ovarian stimulation during IVF-ET.
It is estimated that approximately I% of babies born every year result from in vitro fertilization and embryo transfer (IVF-ET), and other assisted reproductive technologies( 1-4).
The growth and development of the decidua and trophoblast have been shown to be accompanied by changes in the activities of several catabolic enzymes such as adenosine deaminase (ADA) and 5' -nucleotidase (5'-NT) (5) (6) . ADA is a purine metabolic enzyme that is enriched in trophoblast cells of the placenta. The main function of ADA is the development of the immune system in neurotransmission and maintenance of gestation. ADA is a critical enzyme involved in mammalian embryogenesis. It is an early marker of trophoblast cell differentiation, and activating ADA gene expression in the placenta is crucial and essential for proper fetal development (7) (8) . The enhanced expressions of gene encoding ADA may thus be an adaptation to protect the embryo against a lymphotoxic accumulation of purine nucleoside and to maintain an environment permissive to the survival ofT-lymphocytes, a mechanism involved in immunoprotection of the fetus.
The matrix metalloproteinases (MMPs) are thought to play a central role in embryonic development, morphogenesis, reproduction and tissue resorption and remodeling (9) (10) . In humans, MMPs have critical roles throughout various stages of pregnancy, including embryo implantation, trophoblastic invasion, placentation in early gestation and cervical dilatation in later gestation, and feto-maternal membrane lysis. Because firsttrimester cytotrophoblasts have long been used as a model for blastocyst invasion, there is very little information regarding the onset of MMP and TIMP expression in human embryos (11). It is likely that, with better knowledge of implantation events in humans, improvements in reproductive healthcare such as prevention of recurrent pregnancy loss and increased success rates for IVF could follow.
This study was performed to compare serum total ADA (tADA) and isoenzymes ADAl, ADA2, as well as MMP-2, MMP-3, 'MMP-13 and MIP-la between patients with and without the establishment of pregnancy following embryo transfer and whether the above parameters may be used as parameters for pregnancy following embryo transfer.
MATERIALS.AND METHODS
Seventeen women who conceived' (Group A) and nineteen women who did not conceive (Group B) after IVF-ET, aged 21-42 years, were enrolled in the study at 2 nd Department of Obstetrics and Gynecology Medical School Hospital. None of these 36 women had any diseases, including cancer, liver, vascular, or lung in which MMPs have been shown to increase in the patients' sera.
Blood samples were collected between 09.00 and 10.00 a.m. during IVF-ET treatment at two different periods. The first blood sample was collected before ET and the second sample 14 days after ET. The sera were separated by centrifugation (550xg, for 5 min) and kept frozen at -20°C until use.
Serum concentrations of MMP-2, MMP-3, MMP-13, MIP-la were measured using enzyme-linked immunosorbent assay (ELISA) as shown below.
Ovarian stimulation and in vitro fertilization protocol
The patients were stimulated by using a combination of a gonadotrophin releasing hormone (GnRH) agonist started in the luteal phase (suppression protocol) followed by gonadotrophins.
After the onset of withdrawal bleeding, ovarian stimulation was initiated with an injection of FSH at 300 IU/day for 3 days followed by HMG at l50IU/day for >6 days. Ovarian stimulation was monitored by the measurement of serum E2 concentrations and by ultrasonographic assessment of the follicle diameters. The human chorionic gonadotrophin (hCG) injection was administered when at least one of the leading follicles reached 17 mm in diameter. Oocyte retrieval was performed through transvaginal ultrasonography-guided aspiration 36 h after hCG administration. On the second or third day after oocyte retrieval, morphological embryo assessment was performed under an inverted microscope, and the maximum number of good quality embryos transferred was two. For luteal support, progesterone was injected intramuscularly 1-3 days after oocyte retrieval, followed by hCG administration of 2000 IU 2, 4 or 5 and 7 days after oocyte retrieval. Then, 1 tablet/day of E2/P4 was administered daily for 2 weeks from 8 days after oocyte retrieval. Clinical pregnancy was diagnosed 14 days after ET when the gestational sac was revealed under transvaginal ultrasonography.
Assays
All serum samples were assayed for the MMP-2, MMP-3 MMP-13 and MIP-la concentrations with ELISA assay using commercial kits (R&D System).
Serum tADA activity was measured by a spectrophotometer using adenosine as the substrate (Method by Giusti) (12) . The principle of this method is to measure the amount of ammonia liberated during the conversion of adenosine to inosine, using the Berthelot reaction. The results are expressed as U/L in the serum and U/mg protein in PBLS. One Unit of ADA is defined as the amount of enzyme required to release 1 umol of ammonia per minute from adenosine at standard assay conditions.
The activities of ADA2 and tADA in the presence or absence of 0.1 mmol/L EHNA (erythro-9-(2-hydroxy-3nonyl)adenine, Sigma) were measured, and ADA1 activity was calculated by substracting the activity of ADA2 from that of tADA activity. This method is based on the fact that ADA2 has greater resistance to inhibition by EHNA than does ADAI (13) . This method is suitable for reliable quantification of ADA isozymes and analysis of large numbers of samples in clinical laboratories for routine monitoring of the activities ofADA isozymes (14) .
Statistical analyses
All analyses were performed using SPSS. One way analysis of variance was used to test for overall differences among groups. A level ofp<0.05 was accepted as significant.
RESULTS
The patients' characteristics are shown in Table I . There were no significant differences in women's age and frequencies of past IVF-ET treatment between pregnant and non-pregnant women. The results of IVF-ET in women with and without subsequent pregnancy were compared (Table II) .
According to our results, half of the cases of infertility in the two groups were due to male subfertility.
Comparison of tADA and its isoenzymes ADA] and ADA2 between the pregnant and non-pregnant groups
Serum tADA and its isoenzymes ADAI and ADA2 concentrations were assessed on days 0 and 14 following IVF-ET in the pregnant and nonpregnant groups (Fig. I) .
According to our results, women who successfully conceived after IVF-ET showed significantly lower serum concentrations ofADA I at 14 days following ET.
There were significant differences in serum MMP-2, 3 and 13 concentrations between before IVF-ET and on dayl4 in pregnant women (Figs. 2  and 3 ).
DISCUSSION
In the present study it was demonstrated that women who successfully conceived after IVF-ET showed significantly lower serum concentrations of ADAI, MMP-2, MMP-3 and higher serum concentration of MMP-13 at 14 days following ET. Our results demonstrate significantly increased levels of serum ADA and monocyte and lymphocyte counts (data not shown) as indicators of activated cellular immunity in pregnant women when compared to healthy women. Thus, in our study, the increase of tADA in women with successful or unsuccessful pregnancy compared with normal women was perhaps due to exogenous hormone therapy according to the protocol of ovarian stimulation but not in low levels of HCG during successful pregnancy. Total ADA may be affected by the hormone levels (5) (6) 15) . To our knowledge, no other report on hormones and ADA correlation has been published and therefore we could not compare our results with the literature. The isoenzymic pattern of ADA activity in implantation derived by embryo transfer demonstrated a pronounced increase in the levels of tADA synthesized by fetal tissues, between the first two weeks of gestation. ADAI may also playa protective role at the hemochorial interface (7) (8) . Thus, our results suggest thatADAl may have a modulatory role in the implantation and duration of the pregnancy.
Matrix metalloproteinases are synthesized as latent precursors that must be cleaved after secretion to become activated (16) (17) . Ovarian function goes beyond the production of mature oocytes for fertilization and subsequent reproduction. The two major ovarian functions, oocyte and hormone production, are integrally linked to extensive tissue and extracellular matrix remodeling. Specifically, oocyte generation involves follicular development and rupture (ovulation), followed by corpus luteum formation and its regression (luteolysis) (18) (19) .
Here we focus on the role of MMPs in ovolution and corpus luteum formation/regression (20) (21) . The MMPs are thought to be key regulators of the ovarian events, with the MMPs promoting invasion of the various trophoblastic cell types (22) (23) .
This study suggests an important progesteronedependent mechanism to limit the expression and production of MMP-3 in response to inflammatory chemokines such as MIP-l a. MIP-l a may be released by immune cells or invasive trophoblast and is capable of stimulating MMP-3 in proliferative phase stromal cells. After exposure to progesterone however, differentiated stromal cells become insensitive to chemokine mediated MMP-3 stimulation (24) (25) .
Endometrial thickness in the periovulatory period, as measured by transvaginal ultrasonography, has been correlated with clinical pregnancy rate IVF-ET cycles. It has been indicated that retardation in the endometrial development has been linked to low conception rates as well as increased spontaneous abortion rates. In contrast, increased endometrial thickness has recently been reported to have a detrimental effect on implantation rates, pregnancy rates and outcome ofIVF-ET (22) (23) (24) (25) .
Amnion epithelial cells undergo apoptotic cell death before the onset of labor, which is closely associated with degradation of type 1 collagen by collagenase (most likely MMP-13) (24) (25) . The association between the MMP gelatinocytic activity and serum progesterone level at time of transfer is logic as both are factors that enhance embryo implantation. Development and luteolysis of the corpus luteum are accompanied by extensive remodelling of the ECM. Differentiation and regression of luteal cells are associated with construction and degradation of ECM results in luteal cell death. HCG was found to suppress MMP-2 production by human luteinized granulose cells. This in tum leads to rescue of the corpusluteum and hence continuous progesterone production to maintain early pregnancy (23) (24) (25) .
Estrogen alone only weakly inhibits the levels of MMP-2 andMMP-3, 'an effect that can be augmented by the presence of progesterone. The exact mechanism through which progesterone modulates MMP activity remains unclear. However, progesterone has been proposed to regulate MMP activity indirectly through controlling the plasminogen activator pathway. The MMPs are thought to be key regulators for promoting the invasion of the various trophoblastic cell types. The level of MMP-13, which may be one of the triggers of ovulation, increases in the follicular fluid of stimulated IVF patients. This increase is still positively correlated with the level of serum progesterone at time of embryo transfer.
In conclusion, in women with successful or unsuccessful pregnancies compared with normal women the levels ofADA and MMPs may be affected by the exogenous hormone therapy according to the protocol of ovarian stimulation during IVF-ET.
